Please contact us for more information or to learn if you are eligible to participate.
To assess the efficacy of both dose levels of miricorilant versus placebo in reducing liver fat content.
Principal Investigator | Fernando Membreno, MD |
Co-PI | John Rodriguez |
Sponsor | Corcept Therapeutics Incorporated |
Type of Trial | Interventional |